Advisory Board and Editors Genomics
Stephen J Newhouse
Data Science Lead (yak shaver) and Senior Bioinformatician at The Department of Biostatistics and Health Informatics: SLAM NHS NIHR Biomedical Research Centre for Mental Health, Kings College London.
Irene L.G. Newton
Assistant Professor of Biology in the Microbiology section. Woodrow Wilson Foundation Fellow, Andrew Mellon fellow, and advisor to the Social Science Research Counsel, former Howard Hughes Medical Institute Predoctoral Fellow and former NSF postdoctoral fellow.
Tuan V. Nguyen
Dr. Nguyen is Distinguished Professor of Predictive Medicine at the School of Biomedical Engineering, University of Technology Sydney (Australia). He also holds joint appointments as Professor, St Vincent's Clinical School, University of New South Wales (UNSW Sydney); and adjunct Professor of Epidemiology and Biostatistics at the School of Medicine, University of Notre Dame Australia.
Nikolaos Nikoloudakis
Dr. Nikolaos Nikoloudakis is an Assistant Professor at the Cyprus University of Technology (CUT). He graduated (2002) from the Agricultural Biotechnology Department of the Agricultural University of Athens (AUA) and has a MSc in the field of plant biotechnology (2005). He obtained his PhD at the Plant Breeding and Biometry Laboratory (AUA) caring out research involving phylogenetic relationships of Avena species and the study of intergenomic modifications using interspecific hybrids of different ploidy levels (2009). Furthermore, he was a post-doc researcher and a special teaching staff at the Department of Agricultural Sciences, Biotechnology and Food Science (ABF) of the Cyprus University of Technology (2017-2022). He has also served as a technical manager of the national reference laboratories of the Hellenic Ministry of Rural Development and Food, regarding GMO detection in seed lots and the control of pathogenic viruses in plant reproductive material (2011-2016). He has contributed to the formation of research networks as a partner from CUT in several national and European projects and participates in several funded research projects (Horizon 2020, Horizon Europe, Prima, RIF and ECPGR). His main research interests are agricultural biotechnology, plant genetic resources, genotyping, and flow cytometry.
Corey Nislow
Corey Nislow's laboratory develops and uses cutting edge tools to address this central question: how can we understand the biological commonalities in all of the life sciences; from embryonic development, to the spread of infectious diseases to better ways to treat cancer. Each of these disciplines can be explained in the context of competition, interaction and evolution. His lab studies the interface between genes and the environment using parallel genome-wide screens, high throughput cell-based assays and next generation sequencing. Most recently, he and his scientific partner, Dr. Guri Giaever, are exploring how laboratory experiments can co-opt evolutionary processes to understand drug action. He enjoys teaching all aspects of biotechnology, genomics and drug discovery. He got his PhD from the University of Colorado, worked at several Biotechnology companies and was at Stanford and University of Toronto before joining UBC in 2013. He has published 161 papers and run 19 marathons.
Fabrice Not
I'm a staff researcher at CNRS-Station Biologique de Roscoff (France). As a biological oceanographer, my research interest focus on plankton ecology and evolution using genomics and microscopy approaches.
Houtan Noushmehr
Associate scientist and professor of epigenomics and bioinformatics at the department of neurosurgery and genetics.
Rodrigo Nunes-da-Fonseca
Associate Professor at the Center for Ecology and Socio-Environmental Development of Macaé, (NUPEM), Federal University of Rio de Janeiro (UFRJ-Macaé). Affiliate Member of the Brazilian Academy of Sciences (2017-2021). Scientist of Our State at FAPERJ (2019-nowadays), PhD (2008) and Postdoctoral studies (2009) in Functional Genomics and Evolutionary Developmental Biology (Evo-Devo) at the University of Cologne, Germany.
Published more than 85 articles in specialized journals with more than 3500 citations (Google Scholar-Fator H = 24). He serves as a reviewer for several international journals (NAR, Cell Reports, Dev. Gen Evol, Dev. Biol, FEBS J, Plos One, Gene, among others) particularly in the evolutionary genetics of arthropod development.
Lorraine O'Driscoll
Lorraine O'Driscoll (BSc(Hons, Pharm), MSc(Res, Clin Pharm), MA(Ed), PhD(Biotech), FTCD) Lorraine holds a BSc(Hons),pharmacology; MSc(Res), clinical pharmacology; MA, education; PhD, biotechnology. In 2012, she was elected to Fellowship in TCD. Following her PhD, Lorraine undertook biotechnology/biomedical research for US and EU industry (including Berlex; Archport Ltd-Axonobel; MediSyn Ltd; MedaNova Ltd.) before returning to academia. At post-doctoral level, she gained experience at the Dana-Farber Harvard Cancer Institute and University of Miami. Prior to joining TCD in 2008, Lorraine most recently held the position of Senior Research Programme Leader and Lecturer in School of Biotechnology, DCU.
Her research group focuses on diagnostic, prognostic and predictive biomarkers; discovering new therapeutic targets; cancer cells communication via exosomes, microvesicles and CTCs; elucidating and circumventing resistance to targets agents and classical chemotherapy; associations between obesity, metabolic syndrome and cancer.
She has been a P.I. on 5 cancer clinical trials with ICORG. She is TCD's Principal Investigator on SFI-supported Molecular Therapeutics for Cancer Ireland; Strand Leader of Irish Cancer Society-supported Breast-PREDICT; and P.I. and Chair, H2020-supported European Network Cooperation in Science and Technology focussed on Exosomes & Microvesicles in Health & Disease which brings together researchers from around the world, in academia and industry.
Olorunseun O Ogunwobi
Dr. Ogunwobi obtained a medical degree from the University of Ibadan, Nigeria, a master's degree in biomedicine from the University of Hull, United Kingdom, a master's degree in clinical and translational science from the University of Florida, Gainesville, and a PhD in molecular biology from the University of East Anglia, Norwich, United Kingdom. He was the Founding Director of the Hunter College Center for Cancer Health Disparities Research. He is now the Barnett Rosenberg Professor of Biochemistry and Molecular Biology and Chairperson in the Department of Biochemistry and Molecular Biology at Michigan State University. In addition, he will serve as Co-Director of the forthcoming Center for Cancer Health Equity Research (CCHER) at Michigan State University. He is a translational cancer biologist whose work focuses on molecular mechanisms of progression of solid organ cancers with racial disparities, and on approaches to leverage non-coding RNA biology for potential clinical applications in cancer. His work has been funded by the National Institutes of Health, New York State, Carnegie Corporation of New York, and the National Science Foundation, among others. Dr. Ogunwobi was a Founding Contact Principal Investigator of the Synergistic Partnership for Enhancing Equity in Cancer Health (SPEECH) funded by U54 grants CA221704 and CA221705 from the National Cancer Institute. An author of 74 peer-reviewed journal articles and 3 book chapters, Dr. Ogunwobi has been issued 5 US patents for biotechnology inventions with potential clinical applications in cancer. He is the recipient of the 2022 Hunter College Presidential Award for Excellence in Scholarship or Creative Activity, and selected as a Jefferson Science Fellow by the National Academies of Sciences, Engineering, and Medicine, and as a Fellow of the Academy of Medicine Specialties of Nigeria. He is Co-Founder of UTR Therapeutics, Inc (winner of the 2023 XSeed Award from Deerfield), and NucleoBio, Inc.
Brenda Oppert
EDUCATION
University of Texas at El Paso (9/75-8/78), B.S. in Biology, 1978
University of Texas at El Paso (1/83-12/86), M.S. in Biology, 1986
Kansas State University (8/86-5/91), Ph.D. in Biochemistry, 1991
PROFESSIONAL
• Research Molecular Biologist (GS-15), CGAHR, Manhattan, KS (4/91-present)
• Adjunct Professor, Department of Entomology, Kansas State University (1/99-present)
Ludovic Orlando
Ludovic Orlando is a former student from the Ecole Normale Superieure of Lyon (ENS, 1996-2000), one of the top-5 French universities. First trained as a molecular biologist, he got more recently interested in computational biology and programming.
He received his PhD in molecular genetics from the University of Lyon, France in 2003, almost twenty years after the first ancient DNA molecule was ever sequenced. Trained in phylogenomics as a postdoc (CNRS EA 3781), he was rapidly appointed as a permanent Associate Professor at the prestigious ENS Lyon, where he taught and performed research between 2005 and 2010. He moved to the Centre for GeoGenetics, Natural History Museum of Denmark, Copenhagen, in April 2010 to start his own research group. He was appointed as a full Professor in Molecular Archaeology in March 2016 and started in December 2016 a five year, ERC-funded project on horse evolution.
His group develops integrative approaches in ancient DNA research, promoting the field of palaeomics by the merger of biochemistry, molecular biology, genomics and computational biology.